Skip to content
OpenCapital
Get started

LeMaitre Vascular LMAT US — Revenue (Gross)

Other geography segments

DE
$3.98M—
CA
$3.72M—
GB
$3.15M—

Similar metrics at other companies

Merit Medical Systems logo
MMSIUS — Revenue
$226.52M+6.1%
OSI Systems logo
OSISUS — Revenue (Gross)
$140.76M+6.8%
Lantheus Holdings logo
LNTHUS — Revenue
$354.43M-0.9%
Zimmer Biomet Holdings logo
ZBHUS — Revenue
$1.21B+8.6%
The Gorman-Rupp Company logo
GRCUS — Revenue (Gross)
$134.33M+10.1%
Veeco Instruments logo
VECOUS — Revenue (Gross)
$32.23M+33.9%

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's us — revenue (gross).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's US — revenue (gross)?
LeMaitre Vascular (LMAT) reported US — revenue (gross) of $37.19M in Q1 2026.
How has LeMaitre Vascular's US — revenue (gross) changed year-over-year?
LeMaitre Vascular's US — revenue (gross) increased by 7.4% year-over-year, from $34.63M to $37.19M.
What is the long-term trend for LeMaitre Vascular's US — revenue (gross)?
Over 4 years (2021 to 2025), LeMaitre Vascular's US — revenue (gross) has grown at a 10.8% compound annual growth rate (CAGR), from $93.87M to $141.57M.
What does US — revenue (gross) mean?
This metric represents the total gross revenue generated from sales of medical devices within the United States geographic segment, inclusive of any assessed taxes. It serves as a primary indicator of market penetration and demand for the company's vascular surgical products in its domestic market.